SCHEMBL5056708

SCHEMBL5056708

COc1ccc(C(S)(C(N)=O)c2ccccn2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 2/20 0.54
F2 P00734 1/20 0.46
RAB9A P51151 10/20 0.45
NPC1 O15118 8/20 0.45
PKM P14618 5/20 0.45
SMN1; SMN2 Q16637 5/20 0.45
CDK5 Q00535 2/20 0.45
PAX8 Q06710 2/20 0.45
CDK5R1 Q15078 2/20 0.45
HPGD P15428 2/20 0.45
MAPT P10636 4/20 0.44
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
KDM4E B2RXH2 3/20 0.42
ALDH1A1 P00352 3/20 0.42
TDP1 Q9NUW8 2/20 0.42
LMNA P02545 1/20 0.42
HTT P42858 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5052302 0.84 BLM (0.48) SMN1; SMN2MAPTKMT2AMEN1KDM4E
SCHEMBL5060670 0.81 KIF11 (0.50) RAB9ANPC1SMN1; SMN2CDK5CDK5R1
SCHEMBL28637349 0.81 L3MBTL1 (0.50) RAB9ANPC1PKMSMN1; SMN2KMT2A
SCHEMBL5062197 0.81 CA1 (0.52) RAB9ANPC1SMN1; SMN2MAPTALDH1A1
SCHEMBL11632086 0.75 AHR (0.57) AHRF2RAB9ANPC1PKM
SCHEMBL15854868 0.74 AHR (0.81) AHRF2RAB9ANPC1PKM
SCHEMBL31480846 0.74 AHR (0.67) AHRF2RAB9ANPC1PKM
SCHEMBL11721606 0.74 SMN1; SMN2 (0.43) AHRRAB9ANPC1SMN1; SMN2CDK5
SCHEMBL11881295 0.74 KMT2A (0.44) AHRHPGDMAPTKMT2AMEN1
SCHEMBL29060870 0.72 AHR (0.60) AHRF2RAB9ANPC1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080119456-A1 Substituted Thiazoleacetic Acid as Crth2 Ligands 7TM PHARMA A/S (DK) 2008-05-22 US disclosed
EP-1758874-A1 SUBSTITUTED THIAZOLEACETIC ACIDS AS CRTH2 LIGANDS 7TM Pharma A/S (DK) 2007-03-07 EP disclosed
WO-2005116001-A1 SUBSTITUTED THIAZOLEACETIC AS CRTH2 LIGANDS 7TM PHARMA A/S (DK) 2005-12-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119456-A1 Substituted Thiazoleacetic Acid as Crth2 Ligands HRH1, HRH2, HRH3 AHR 63/4885F2 3909/4885RAB9A 2363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.